Shepherd Financial Partners LLC Cuts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Shepherd Financial Partners LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,216 shares of the exchange traded fund’s stock after selling 1,234 shares during the quarter. Shepherd Financial Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $830,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Sanctuary Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $1,247,000. GAMMA Investing LLC raised its holdings in SPDR S&P Biotech ETF by 7,173.3% in the third quarter. GAMMA Investing LLC now owns 1,091 shares of the exchange traded fund’s stock worth $108,000 after buying an additional 1,076 shares during the last quarter. CWM LLC lifted its stake in shares of SPDR S&P Biotech ETF by 22.0% in the third quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock worth $1,012,000 after buying an additional 1,849 shares in the last quarter. Carnegie Investment Counsel grew its holdings in shares of SPDR S&P Biotech ETF by 3.2% during the third quarter. Carnegie Investment Counsel now owns 95,423 shares of the exchange traded fund’s stock valued at $9,428,000 after buying an additional 2,975 shares during the last quarter. Finally, Shaker Investments LLC OH increased its position in shares of SPDR S&P Biotech ETF by 63.5% during the third quarter. Shaker Investments LLC OH now owns 9,575 shares of the exchange traded fund’s stock valued at $946,000 after acquiring an additional 3,720 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.3 %

XBI stock opened at $91.24 on Friday. The stock’s 50 day simple moving average is $92.58 and its 200 day simple moving average is $96.50. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market capitalization of $6.95 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.